Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner.

Published on Dec 10, 2019in Scientific Reports3.998
· DOI :10.1038/S41598-019-55296-3
Reika Shiratori2
Estimated H-index: 2
(Chiba University),
Kenta Furuichi1
Estimated H-index: 1
(Chiba University)
+ 5 AuthorsShigeki Aoki7
Estimated H-index: 7
(Chiba University)
Most cancer cells rely on glycolysis to generate ATP, even when oxygen is available. However, merely inhibiting the glycolysis is insufficient for the eradication of cancer cells. One main reason for this is that cancer cells have the potential to adapt their metabolism to their environmental conditions. In this study, we investigated how cancer cells modify their intracellular metabolism when glycolysis is suppressed, using PANC-1 pancreatic cancer cells and two other solid tumor cell lines, A549 and HeLa. Our study revealed that glycolytically suppressed cells upregulated mitochondrial function and relied on oxidative phosphorylation (OXPHOS) to obtain the ATP necessary for their survival. Dynamic changes in intracellular metabolic profiles were also observed, reflected by the reduced levels of TCA cycle intermediates and elevated levels of most amino acids. Glutamine and glutamate were important for this metabolic reprogramming, as these were largely consumed by influx into the TCA cycle when the glycolytic pathway was suppressed. During the reprogramming process, activated autophagy was involved in modulating mitochondrial function. We conclude that upon glycolytic suppression in multiple types of tumor cells, intracellular energy metabolism is reprogrammed toward mitochondrial OXPHOS in an autophagy-dependent manner to ensure cellular survival.
Figures & Tables
📖 Papers frequently viewed together
748 Citations
3 Authors (Angela M. Liu, ..., John M. Luk)
#1Nitin Jain (University of Texas MD Anderson Cancer Center)H-Index: 43
#2Michael J. Keating (University of Texas MD Anderson Cancer Center)H-Index: 163
Last. William G. Wierda (University of Texas MD Anderson Cancer Center)H-Index: 114
view all 32 authors...
Abstract Background Ibrutinib, an inhibitor of Bruton’s tyrosine kinase, and venetoclax, an inhibitor of B-cell lymphoma 2 protein, have been approved for patients with chronic lymphocytic leukemia...
201 CitationsSource
#1Pouya Saraei (Semnan University)H-Index: 1
#2Ilia Asadi (Semnan University)H-Index: 1
Last. Nasroallah Moradi-Kor (Semnan University)H-Index: 4
view all 4 authors...
: Metformin is a widely used drug in today's prescriptions by physicians due to its specific effects in treating and curing type II diabetes. Diabetes is a common disease that may occur throughout human life, and can increase the likelihood of the occurrence of various types of cancer, such as colon, rectum, pancreas and liver cancers, compared to non-diabetic patients. Metformin inhibits mTOR activity by activating ATM (ataxia telangiectasia mutated) and LKB1 (liver kinase B1) and then adenosin...
94 CitationsSource
#1Dongya Jia (Rice University)H-Index: 19
#2Mingyang LuH-Index: 29
Last. Herbert Levine (Rice University)H-Index: 89
view all 8 authors...
Metabolic plasticity enables cancer cells to switch their metabolism phenotypes between glycolysis and oxidative phosphorylation (OXPHOS) during tumorigenesis and metastasis. However, it is still largely unknown how cancer cells orchestrate gene regulation to balance their glycolysis and OXPHOS activities. Previously, by modeling the gene regulation of cancer metabolism we have reported that cancer cells can acquire a stable hybrid metabolic state in which both glycolysis and OXPHOS can be used....
123 CitationsSource
#1Laura Hulea (McGill University)H-Index: 15
#2Simon-Pierre Gravel (McGill University)H-Index: 17
Last. Ivan TopisirovicH-Index: 56
view all 28 authors...
Summary There is increasing interest in therapeutically exploiting metabolic differences between normal and cancer cells. We show that kinase inhibitors (KIs) and biguanides synergistically and selectively target a variety of cancer cells. Synthesis of non-essential amino acids (NEAAs) aspartate, asparagine, and serine, as well as glutamine metabolism, are major determinants of the efficacy of KI/biguanide combinations. The mTORC1/4E-BP axis regulates aspartate, asparagine, and serine synthesis ...
35 CitationsSource
#1Daniel A. Pollyea (University of Colorado Denver)H-Index: 49
#2Brett M. Stevens (University of Colorado Denver)H-Index: 18
Last. Craig T. Jordan (University of Colorado Denver)H-Index: 71
view all 17 authors...
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Leukemia stem cells (LSCs) drive the initiation and perpetuation of AML, are quantifiably associated with worse clinical outcomes, and often persist after conventional chemotherapy resulting in relapse1–5. In this report, we show that treatment of older patients with AML with the B cell lymphoma 2 (BCL-2) inhibitor venetoclax in combination with azacitidine results in deep and durable remissions and is superior to conventi...
235 CitationsSource
#1Hirofumi Ukai (Osaka University)H-Index: 2
#2Yasuhiro Araki (Osaka University)H-Index: 16
Last. Takeshi Noda (Osaka University)H-Index: 64
view all 6 authors...
TORC1 is a central regulator of cell growth in response to amino acids. The role of the evolutionarily conserved Gtr/Rag pathway in the regulation of TORC1 is well-established. Recent genetic studies suggest that an additional regulatory pathway, depending on the activity of Pib2, plays a role in TORC1 activation independently of the Gtr/Rag pathway. However, the interplay between the Pib2 pathway and the Gtr/Rag pathway remains unclear. In this study, we show that Pib2 and Gtr/Ego form distinct...
25 CitationsSource
Cancer cells are highly dependent on metabolic pathways to sustain both their proliferation and adaption to harsh microenvironments. Thus, understanding the metabolic reprogramming that occurs in tumors can provide critical insights for the development of therapies targeting metabolism. In this review, we will discuss recent advancements in metabolomics and other multidisciplinary techniques that have led to the discovery of novel metabolic pathways and mechanisms in diverse cancer types.
34 CitationsSource
#1Takuya Hirao (Chiba University)H-Index: 3
#2Masashi Yamaguchi (Chiba University)H-Index: 20
Last. Shigeki Aoki (Chiba University)H-Index: 7
view all 6 authors...
Tyrosine kinase inhibitors (TKI), including imatinib (IM), improve the outcome of CML therapy. However, TKI treatment is long-term and can induce resistance to TKI, which often leads to a poor clinical outcome in CML patients. Here, we examined the effect of continuous IM exposure on intracellular energy metabolism in K562 cells, a human Philadelphia chromosome-positive CML cell line, and its subsequent sensitivity to anti-cancer agents. Contrary to our expectations, we found that continuous IM ...
16 CitationsSource
#1Shigeki Aoki (Chiba University)H-Index: 7
#2Michie Morita (Chiba University)H-Index: 2
Last. Kousei Ito (Chiba University)H-Index: 29
view all 8 authors...
// Shigeki Aoki 1, * , Michie Morita 1, * , Takuya Hirao 1 , Masashi Yamaguchi 2 , Reika Shiratori 1 , Megumi Kikuya 1 , Hiroji Chibana 2 and Kousei Ito 1 1 Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba-city, Chiba 260-8675, Japan 2 Medical Mycology Research Center, Chiba University, Chiba-city, Chiba 260-8673, Japan * These authors have contributed equally to this work Correspondence to: Shigeki Aoki, email: Keywords: ...
22 CitationsSource
#1Elodie Villa (French Institute of Health and Medical Research)H-Index: 10
#2Emma Proïcs (French Institute of Health and Medical Research)H-Index: 4
Last. Jean-Ehrland Ricci (French Institute of Health and Medical Research)H-Index: 37
view all 14 authors...
Mitophagy is an evolutionarily conserved process that selectively targets impaired mitochondria for degradation. Defects in mitophagy are often associated with diverse pathologies, including cancer. Because the main known regulators of mitophagy are frequently inactivated in cancer cells, the mechanisms that regulate mitophagy in cancer cells are not fully understood. Here, we identified an E3 ubiquitin ligase (ARIH1/HHARI) that triggers mitophagy in cancer cells in a PINK1-dependent manner. We ...
126 CitationsSource
Cited By46
Immune escape is one of the hallmarks of cancer. While metabolic reprogramming provides survival advantage to tumor cancer cells, accumulating data also suggest such metabolic rewiring directly affects the activation, differentiation and function of immune cells, particularly in the tumor microenvironment. Understanding how metabolic reprogramming affects both tumor and immune cells, as well as their interplay, is therefore critical to better modulate tumor immune microenvironment in the era of ...
#1Shonagh Russell (USF: University of South Florida)H-Index: 7
#2Liping XuH-Index: 15
Last. E. Ruiz
view all 15 authors...
Abstract null Aggressive cancers commonly ferment glucose to lactic acid at high rates, even in the presence of oxygen. This is known as aerobic glycolysis, or the “Warburg Effect”. It is widely assumed that this is a consequence of the upregulation of glycolytic enzymes. Oncogenic drivers can increase the expression of most proteins in the glycolytic pathway, including the terminal step of exporting H+ equivalents from the cytoplasm. Proton exporters maintain an alkaline cytoplasmic pH, which c...
#1Qianqian Sun (HEU: Harbin Engineering University)
#2Bin Liu (HEU: Harbin Engineering University)H-Index: 85
Last. Piaoping Yang (HEU: Harbin Engineering University)H-Index: 79
view all 10 authors...
Mitochondria are the "power plant" of the cell, providing a constant source of energy, and are involved in a variety of intracellular signaling pathways. Among these pathways, Ca2+ homeostasis is closely related to the normal function of mitochondria. By destroying the Ca2+ steady state of mitochondria and disrupting their multiple cellular activities, tumor cell killing can be achieved. In addition, the presence of an intracellular oxidative stress state triggers the closure of cellular calcium...
#1Megumi Kikuya (Chiba University)H-Index: 2
#2Kenta Furuichi (Chiba University)H-Index: 1
Last. Shigeki Aoki (Chiba University)H-Index: 7
view all 7 authors...
Abstract Tyrosine kinase inhibitors (TKIs) are widely utilized in clinical practice to treat carcinomas, but secondary tumor resistance during chronic treatment can be problematic. AKR1B1 and AKR1B10 of the aldo-keto reductase (AKR) superfamily are highly expressed in cancer cells and are believed to be involved in drug resistance. The aim of this study was to understand how TKI treatment of chronic myelogenous leukemia (CML) cells changes their glucose metabolism and if inhibition of AKRs can s...
#1Kouminin Kanwore (Xuzhou Medical College)H-Index: 2
#2Piniel Alphayo Kambey (Xuzhou Medical College)H-Index: 1
Last. Dian-Shuai Gao (Xuzhou Medical College)H-Index: 16
view all 6 authors...
The external and internal factors of the cell are critical to glioma initiation. Several factors and molecules have been reported to be implicated in the initiation and progression of brain cancer. However, the exact sequence of events responsible for glioma initiation is still unknown. Existing reports indicate that glioma stem cells are the cell of glioma origin. During cell division, chromosome breakage, DNA alteration increases the chance of the cell genome modifications and oncogene overexp...
#1Danming Tang (Genentech)H-Index: 15
#2Wendy Sandoval (Genentech)H-Index: 28
Last. Shahram Misaghi (Genentech)H-Index: 19
view all 6 authors...
Deletion of the pyruvate kinase muscle (PKM) gene, which is involved in conversion of phosphoenolpyruvate to pyruvate, has been shown to curb lactogenic behavior in Chinese hamster ovary (CHO) cells. This study describes the generation of pyruvate kinase muscle isoforms 1 and 2 knockout (PKM-KO) and pyruvate kinase muscle isoform-1 knockout (PKM1-KO) CHO host cells to understand metabolic shifts that reduce lactate secretion in these cells. Glucose and amino acids uptake levels in wild-type (WT)...
#1Taisei Kanamori (Chiba University)H-Index: 1
#2Natumi Miyazaki (Chiba University)H-Index: 1
Last. Hiroto Hatakeyama (Chiba University)H-Index: 33
view all 6 authors...
Despite progress in the use of hyperthermia in clinical practice, the thermosensitivity of cancer cells is poorly understood. In a previous study, we found that sensitivity to hyperthermia varied between ovarian and uterine cancer cell lines. Upon hyperthermia, glycolytic enzymes decreased in hyperthermia-resistant SKOV3 cells. However, the mechanisms of glycolysis inhibition and their relationship with thermoresistance remain to be explored. In this study, metabolomic analysis indicated the dow...
1 CitationsSource
#1Zahra Ghanbari Movahed (Kermanshah University of Medical Sciences)H-Index: 1
#2Reza Yarani (Steno Diabetes Center)H-Index: 9
Last. Kamran Mansouri (Kermanshah University of Medical Sciences)H-Index: 21
view all 4 authors...
Abstract Tumor angiogenesis plays a vital role in tumor growth and metastasis. It is proven that in tumor vasculature, endothelial cells (ECs) originate from a small population of cancer cells introduced as cancer stem cells (CSCs). Autophagy has a vital role in ECs differentiation from CSCs and tumor angiogenesis. High levels of reactive oxygen species (ROS) increased autophagy by inhibition of glucose-6-phosphate dehydrogenase (G6PD) and inactivation of the pentose phosphate pathway (PPP). Pre...
2 CitationsSource
#1Damian Hertig (University of Bern)H-Index: 3
#2Sally Maddah (University of Bern)
Last. Peter Vermathen (University of Bern)H-Index: 31
view all 9 authors...
BACKGROUND Because of the interplay between mitochondrial respiration and cellular metabolism, the simultaneous monitoring of both cellular processes provides important insights for the understanding of biological processes. NMR flow systems provide a unique window into the metabolome of cultured cells. Simplified bioreactor construction based on commercially available flow systems increase the practicability and reproducibility of bioreactor studies using standard NMR spectrometers. We therefor...
#1Elisabetta Grillo (University of Brescia)H-Index: 10
#2Michela Corsini (University of Brescia)H-Index: 12
Last. Stefania Mitola (University of Brescia)H-Index: 32
view all 9 authors...
Abstract Vascular endothelial growth factor receptor 2 (VEGFR2) activating mutations are emerging as important oncogenic driver events. Understanding the biological implications of such mutations may help to pinpoint novel therapeutic targets. Here we show that activated VEGFR2 via the pro-oncogenic R1051Q mutation induces relevant metabolic changes in melanoma cells. The expression of VEGFR2R1051Q leads to higher energy metabolism and ATP production compared to control cells expressing VEGFR2WT...
2 CitationsSource